Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer
Eugenia Girda(Rutgers, The State University of New Jersey), Lorna Rodrı́guez-Rodrı́guez(City Of Hope National Medical Center)
Cited by 14